RTX’s BBN Technologies division secured a DARPA contract to develop advanced kilometer-range X-ray imaging algorithms. The project will reconstruct hidden object geometries from up to 1 km using mathematical modeling and image analysis in collaboration with Georgia Institute of Technology to enhance situational awareness.

RTX’s Raytheon ELCAN division won contracts with German Armed Forces involving Aimpoint® reflex sights and customized Specter DR configurations. Total orders across Europe since August 2024 exceed €193 million, reflecting rising demand for versatile combat optics.

RTX shares declined 1.31% on the day while the S&P 500 gained 0.69%, trading 1.4% below its 20-day simple moving average and 4.5% below its 100-day average. Technical metrics show neutral RSI at 44.45 and bearish MACD, indicating mixed momentum despite a 74% year-over-year gain.

RTX is set to report its next earnings on April 21, with analysts projecting EPS of $1.51 and revenue of $21.39 billion, up from prior estimates. The stock trades at a 40.0x P/E and carries buy ratings with average price targets near $230, highlighting premium valuation expectations.